← Back to Search

Facebook Intervention for Skin Cancer

N/A
Recruiting
Led By Sharon Manne
Research Sponsored by Rutgers, The State University of New Jersey
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Patient does not have a concurrent cancer diagnosis
Patient age at diagnosis 18-39 years
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights
No Placebo-Only Group

Summary

This trial studies how well two types of Facebook interventions work in improving skin examination in participants with melanoma and their families. The interventions may help improve total cutaneous examinations, skin self-examinations, and sun protection among those studied.

Who is the study for?
This trial is for melanoma patients diagnosed within the last 5 years, aged 18-39, who've completed treatment at least 3 months ago. They must have internet access, a Facebook account, and be able to understand English. Their family members (aged 18-80) without personal melanoma history can join if they haven't had thorough skin exams recently or often do self-exams or use sun protection.
What is being tested?
The study tests two Facebook-based interventions: one focused on young melanoma families and another on healthy lifestyles. The goal is to see if these online programs increase skin examinations by patients and their relatives as well as improve their sun protection habits.
What are the potential side effects?
Since this trial involves informational interventions through Facebook rather than medical treatments, there are no direct physical side effects expected from participation in the study.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I do not have any other cancer diagnosis.
Select...
I was diagnosed with my condition between the ages of 18 and 39.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 5 years for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Total cutaneous examination (TCE)
Secondary study objectives
Skin Self-exam (Relatives)
Skin
Skin self-exam - Comprehensiveness (Relatives)
+4 more
Other study objectives
Mediator analyses - (Relatives)
Mediator analyses - Intervention Group
Mediator analyses - Intervention Group - Barriers
+12 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Group I: Arm 2 Healthy Lifestyle Facebook focusing on healthy lifestyleExperimental Treatment2 Interventions
Participants join a secret Healthy Lifestyle Facebook Group and view post messages focusing on healthy lifestyle for 12 weeks.
Group II: Arm 1 Young melanoma Family Facebook focusing on skin cancerExperimental Treatment2 Interventions
Participants join a secret Young melanoma Family Facebook Group and view post messages focusing on skin cancer for 12 weeks.

Find a Location

Who is running the clinical trial?

National Cancer Institute (NCI)NIH
13,956 Previous Clinical Trials
41,110,923 Total Patients Enrolled
5 Trials studying Cutaneous Melanoma
146 Patients Enrolled for Cutaneous Melanoma
Rutgers, The State University of New JerseyLead Sponsor
454 Previous Clinical Trials
68,717 Total Patients Enrolled
Sharon MannePrincipal Investigator - Rutgers Cancer Institute of New Jersey
Rutgers Cancer Institute of New Jersey
4 Previous Clinical Trials
128 Total Patients Enrolled

Media Library

Informational Intervention Clinical Trial Eligibility Overview. Trial Name: NCT03677739 — N/A
Cutaneous Melanoma Research Study Groups: Arm 1 Young melanoma Family Facebook focusing on skin cancer, Arm 2 Healthy Lifestyle Facebook focusing on healthy lifestyle
Cutaneous Melanoma Clinical Trial 2023: Informational Intervention Highlights & Side Effects. Trial Name: NCT03677739 — N/A
Informational Intervention 2023 Treatment Timeline for Medical Study. Trial Name: NCT03677739 — N/A
~82 spots leftby Jun 2025